A FORENSIC audit into alleged drug pilferage has revealed that ZAMMSA’s K685 million medical supply mop-up exercise was initiated by the Ministry of Commerce and influenced by a Pharmaceutical Society meeting that aimed to exaggerate the procurement of medicines. PwC conducted a forensic audit into alleged drug pilferage, specifically concerning drugs procured using funds from USAID and other cooperating partners, covering January 2023 to July 2024. The forensic audit report noted that ZAMMSA conducted an open tender process for its mop-up exercise between November 2023 and February 2024, awarding contracts valued at K685 million to 24 suppliers. Despite procurement procedures appearing to have been followed, the audit uncovered concerns upon a detailed review. “One of the functions of ZAMMSA, which...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here